Next Article in Journal
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot
Next Article in Special Issue
Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges
Previous Article in Journal
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
Previous Article in Special Issue
Towards a Four-Component GMMA-Based Vaccine against Shigella
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 340; https://doi.org/10.3390/vaccines10020340
Action Date Notes Link
article xml file uploaded 21 February 2022 12:50 CET Original file -
article xml uploaded. 21 February 2022 12:50 CET Update https://www.mdpi.com/2076-393X/10/2/340/xml
article pdf uploaded. 21 February 2022 12:50 CET Version of Record https://www.mdpi.com/2076-393X/10/2/340/pdf
article supplementary file uploaded. 21 February 2022 12:50 CET - https://www.mdpi.com/2076-393X/10/2/340#supplementary
article html file updated 21 February 2022 12:52 CET Original file -
article html file updated 1 August 2022 01:47 CEST Update https://www.mdpi.com/2076-393X/10/2/340/html
Back to TopTop